Deactivated Cas9-Engineered Magnetic Micromotors toward a Point-of-Care Digital Viral RNA Assay
- 28 February 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (9) , 8646-8660
Abstract
Digital nucleic acid assays, known for their high sensitivity and specificity, typically rely on fluorescent readouts and expensive and complex nanowell manufacturing, which constrain their broader use in point-of-care (POC) application. Here, we introduce an alternative digital molecular diagnostics, termed dCRISTOR, by seamlessly integrating deactivated Cas9 (dCas9)-engineered micromotors, extraction-free loop-mediated isothermal amplification (LAMP), low-cost bright field microscopy, and deep learning-enabled image processing. The micromotor, composed of a polystyrene sphere attached to a magnetic bead, incorporates a dCas9 ribonucleoprotein complex. The presence of human immunodeficiency virus-1 (HIV-1) RNA in a sample results in the formation of large-sized amplicons that can be specifically captured by the micromotors, reducing their velocity induced by an external magnetic field. The micromotor is propelled by an external magnetic field, which eliminates the need for chemical fuels, reducing system complexity, and allowing for precise control over micromotor movement, enhancing accuracy and reliability. A convolutional neural network classification-based multiobject tracking algorithm, CNN-MOT, accurately measures the change in micromotor motion, facilitating the binary digital assay format ("1" or "0") for simplified result interpretation without user bias. Incorporating an extraction-free LAMP assay streamlines the dCRISTOR workflow, enabling qualitative HIV-1 detection in spiked plasma (n = 21) that demonstrates 100% sensitivity and specificity and achieves a limit of detection (LOD) of 0.96 copies/μL. The assay also achieved 100% correlation with reverse transcription-quantitative polymerase chain reaction (RT-qPCR) in clinical patient samples (n = 9). The dCRISTOR assay, a label-free digital nucleic acid testing system that eliminates the need for fluorescence readouts, absorbance measurements, or expensive manufacturing processes, represents a substantial advancement in digital viral RNA diagnostics.Keywords
Funding Information
- Brigham and Women's Hospital
- National Institute of Health Sciences (R01AI138800, R01AI138800-05S1, R01EB033866, R01HD115677, R33AI140489, R61AI140489, U54HL119145)
This publication has 54 references indexed in Scilit:
- Digital Recombinase Polymerase Amplification, Digital Loop‐Mediated Isothermal Amplification, and Digital CRISPR‐Cas Assisted Assay: Current Status, Challenges, and PerspectivesSmall, 2023
- Plasmonic-magnetic nanorobots for SARS-CoV-2 RNA detection through electronic readoutApplied Materials Today, 2022
- Deep‐dLAMP: Deep Learning‐Enabled Polydisperse Emulsion‐Based Digital Loop‐Mediated Isothermal AmplificationAdvanced Science, 2022
- Engineering Magnetic Micro/Nanorobots for Versatile Biomedical ApplicationsAdvanced Intelligent Systems, 2021
- Fully integrated microfluidic devices for qualitative, quantitative and digital nucleic acids testing at point of careBiosensors and Bioelectronics, 2021
- Digital CRISPR/Cas‐Assisted Assay for Rapid and Sensitive Detection of SARS‐CoV‐2Advanced Science, 2020
- Droplet and Microchamber‐Based Digital Loop‐Mediated Isothermal Amplification (dLAMP)Small, 2020
- Nano/Micromotors for Diagnosis and Therapy of Cancer and Infectious DiseasesChemistry – A European Journal, 2019
- Particle tracking in living cells: a review of the mean square displacement method and beyondRheologica Acta, 2013
- Antifouling Coatings: Recent Developments in the Design of Surfaces That Prevent Fouling by Proteins, Bacteria, and Marine OrganismsAdvanced Materials, 2010